Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: A randomized, controlled study

American Journal of Obstetrics and Gynecology

Volumn 183, Issue 4, 2000, Pages 998-1002

  Ashok, Premila W ^a   Flett, Gillian M M ^a   Templeton, Allan ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Induced abortion; Mifepristone; Misoprostol

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ADULT; BLEEDING; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FIRST TRIMESTER PREGNANCY; HEADACHE; HEALTH HAZARD; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; OPERATION DURATION; PERIOPERATIVE PERIOD; PREGNANCY COMPLICATION; PREGNANCY TERMINATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TREATMENT OUTCOME; UTERINE CERVIX DILATATION; VACUUM ASPIRATION;

EID: 0033784807     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2000.106767     Document Type: Conference Paper

References (22)

1. Measures to prevent cervical injury during suction curettage abortion
2. Prevention of uterine perforation during curettage abortion
3. Cervical priming with prostaglandin analogues, misoprostol and gemeprost
4. A randomised comparison of oral and vaginal misoprostol for cervical priming before suction termination of pregnancy
5. The use of mifepristone (RU 486) for cervical preparation in first trimester pregnancy termination by vacuum aspiration
6. Pre-operative cervical preparation before first trimester vacuum aspiration: A randomized controlled comparison between gemeprost and mifepristone (RU 486)
7. Use of a force measuring instrument during cervical dilatation
8. Mifepristone (RU 486) for cervical priming prior to surgically induced abortion in the late first trimester
9. An effective regimen for early medical abortion: A report of 2000 consecutive cases
10. Non-surgical midtrimester termination of pregnancy: A review of 500 consecutive cases
11. Termination of pregnancy at 9-13 weeks amenorrhoea with mifepristone and misoprostol
12. Complications from legally-induced abortion: A review
13. Oral misoprostol versus mifepristone for cervical dilatation before vacuum aspiration in first trimester nulliparous pregnancy: A double blind prospective randomised study
14. Induced cervical ripening with mifepristone (RU 486) and bioconversion of arachidonic acid in human pregnant uterine cervix in the first trimester
15. Effects of gemeprost and mifepristone on the mechanical properties of the cervix prior to first trimester termination of pregnancy
16. The effects of RU-38486 on cervical ripening
17. A comparative study using two dose regimens (200 μg or 400 μg) of vaginal misoprostol for pre-operative cervical dilatation in first trimester nulliparae
18. Induction of abortion with mifepristone (RU486) and oral or vaginal misoprostol